Check out the companies making headlines in midday trading: UnitedHealth — Shares plunged 7.2% after the health-care giant lowered its earnings guidance due to ongoing headwinds from a cyberattack earlier in the year. UnitedHealth cut the top end of its full-year earnings forecast, which is now $27.50 to $27.75 per share, compared to previous guidance of $27.50 to $28.00 per share. UnitedHealth still reported a top- and bottom-line beat in the third quarter. Walgreens Boots Alliance — The stock soared 11.9% following the drugstore chain’s fiscal fourth-quarter earnings and revenue beat. Walgreens also plans to close about 1,200 stores over the next three years, which will be “immediately accretive” to its adjusted earnings and cash flow, the company said. ASML — Shares dropped more than 16% after the Dutch semiconductor equipment maker released its earnings report early and offered a weaker-than-expected sales outlook for 2025. The company’s CEO also warned of a “more gradual” recovery ahead. Other chip stocks fell as well, with Nvidia , Advanced Micro Devices and Broadcom last down at least 4% each. Wolfspeed — Shares popped 23% on news that the North Carolina-based chipmaker will obtain up to $750 million in U.S. government grants for its new factories in North Carolina and New York. A group of investors including Apollo and Baupost will provide an additional $750 million in funding for its more than $6 billion plan. Bank of America — The lender saw shares gain 2% after it exceeded analysts’ estimates for third-quarter profit and revenue on better-than-expected trading results. Net interest income, one of the key ways that banks make money, fell 2.9% to $14.1 billion, edging out the $14.06 billion StreetAccount estimate. Enphase Energy — Shares slid 6.8% on the back of a downgrade to sector perform from outperform by RBC Capital Markets. The firm said Enphase should grow at a slower rate than the consensus forecast pencils in. Johnson & Johnson — The health-care conglomerate gained 1.6% after posting quarterly results that exceeded expectations on the back of strong sales of oncology drugs. Johnson & Johnson reported adjusted earnings per share of $2.42 and $22.47 billion in revenue. Meanwhile, analysts surveyed by LSEG had forecast $2.21 in earnings per share on $22.16 billion in revenue. The firm also raised guidance for its 2024 profit and sales. Energy stocks — Energy stocks declined as oil prices dropped about 5% , with the sector last down more than 2%. APA was the biggest laggard, tumbling 6%. Diamondback Energy tanked 4.3%, while Occidental Petroleum , Valero Energy and Halliburton lost more than 3% each. Coty — The CoverGirl parent plunged 11% after trimming its fiscal first-quarter guidance and warning of slower growth trends in the U.S. Citigroup — Shares lost about 4% despite stronger-than-expected third-quarter earnings . The bank posted earnings per share of $1.51 on $20.32 billion in revenue. Analysts polled by LSEG had anticipated earnings of $1.31 per share on revenue of $19.48 billion. Charles Schwab — Shares of the brokerage company rallied more than 8% as third-quarter results topped analysts’ expectations. The company posted earnings of 77 cents, excluding one-time items, on $4.85 billion in revenue. PNC Financial — The Pittsburgh-based regional bank rose more than 3% on a better-than-expected earnings report. Earnings came in at $3.49, topping an LSEG estimate of $3.30 per share. The company reported $5.43 billion in revenue, topping a forecast of $5.39 billion. Boeing — Shares added about 2.1% after the aircraft manufacturer said it could raise up to $25 billion in debt and shares to increase liquidity. — CNBC’s Yun Li, Alex Harring, Hakyung Kim, Michelle Fox, Pia Singh, Sarah Min contributed reporting.
Smart robotic arms work on the production line at the production workshop of Changqing Auto Parts Co., LTD., located in Anqing Economic Development Zone, Anhui Province, China, on March 13, 2025. (Photo by Costfoto/NurPhoto via Getty Images)
Nurphoto | Nurphoto | Getty Images
BEIJING — China missed several key targets from its 10-year plan to become self-sufficient in technology, while fostering unhealthy industrial competition which worsened global trade tensions, the European Chamber of Commerce in China said in a report this week.
When Beijing released its “Made in China 2025” plan in 2015, it was met with significant international criticism for promoting Chinese business at the expense of their foreign counterparts. The country subsequently downplayed the initiative, but has doubled-down on domestic tech development given U.S. restrictionsin the last several years.
Since releasing the plan,China has exceeded its targets on achieving domestic dominance in autos, but the country has not yet reached its targets in aerospace, high-end robots and the growth rate of manufacturing value-added, the business chamber said, citing its research and discussions with members. Out of ten strategic sectors identified in the report, China only attained technological dominance in shipbuilding, high-speed rail and electric cars.
China’s targets are generally seen as a direction rather than an actual figure to be achieved by a specific date. The Made In China 2025 plan outlines the first ten years of what the country called a ‘multi-decade strategy’ to become a global manufacturing powerhouse.
The chamber pointed out that China’s self-developed airplane, the C919, still relies heavily on U.S. and European parts and though industrial automation levels have “increased substantially,” it is primarily due to foreign technology. In addition, the growth rate of manufacturing value add reached 6.1% in 2024, falling from the 7% rate in 2015 and just over halfway toward reaching the target of 11%.
“Everyone should consider themselves lucky that China missed its manufacturing growth target,” Jens Eskelund, president of the European Union Chamber of Commerce in China, told reporters Tuesday, since the reverse would have exacerbated pressure on global competitors. “They didn’t fulfill their own target, but I actually think they did astoundingly well.”
Even at that slower pace, China has transformed itself over the last decade to drive 29% of global manufacturing value add — almost the same as the U.S. and Europe combined, Eskelund said. “Before 2015, in many, many categoriesChina was not a direct competitor of Europe and the United States.”
The U.S. in recent years has sought to restrict China’s access to high-end tech, and encourage advanced manufacturing companies to build factories in America.
The U.S. restrictions have “pushed us to make things that previously we would not have thought we had to buy,” said Lionel M. Ni, founding president of the Guangzhou campus of the Hong Kong University of Science and Technology. That’s according to a CNBC translation of his Mandarin-language remarks to reporters on Wednesday.
Ni said the products requiring home-grown development efforts included chips and equipment, and if substitutes for restricted items weren’t immediately available, the university would buy the second-best version available.
In addition to thematic plans, China issues national development priorities every five years. The current 14th five-year plan emphasizes support for the digital economy and wraps up in December. The subsequent 15th five-year plan is scheduled to be released next year.
China catching up
It remains unclear to what extent China can become completely self-sufficient in key technological systems in the near term. But local companies have made rapid strides.
“Western chip export controls have had some success in that they briefly set back China’s developmental efforts in semiconductors, albeit at some cost to the United States and allied firms,” analysts at the Washington, D.C.,-based think tank Center for Strategic and International Studies, said in a report this week. However, they noted that China has only doubled down, “potentially destabilizing the U.S. semiconductor ecosystem.”
For example, the thinktank pointed out, Huawei’s current generation smartphone, the Pura 70 series, incorporates 33 China-sourced components and only 5 sourced from outside of China.
Huawei reported a 22% surge in revenue in 2024 — the fastest growth since 2016 — buoyed by a recovery in its consumer products business.The company spent 20.8% of its revenue on research and development last year, well above its annual goal of more than 10%.
Overall, China manufacturers reached the nationwide 1.68% target for spending on research and development as a percentage of operating revenue, the EU Chamber report said.
“‘Europe needs to take a hard look at itself,” Eskelund said, referring to Huawei’s high R&D spend. “Are European companies doing what is needed to remain at the cutting edge of technology?”
However, high spending doesn’t necessarily mean efficiency.
The electric car race in particular has prompted a price war, with most automakers running losses in their attempt to undercut competitors. The phenomenon is often called “neijuan” or “involution” in China.
“We also need to realize [China’s] success has not come without problems,” Eskelund said. “We are seeing across a great many industries it has not translated into healthy business.”
He added that the attempt to fulfill “Made in China 2025” targets contributed to involution, and pointed out that China’s efforts to move up the manufacturing value chain from Christmas ornaments to high-end equipment have also increased global worries about security risks.
Weekly analysis and insights from Asia’s largest economy in your inbox Subscribe now
Such fierce competition compounds the impact of already slowing economic growth. Out of 2,825 mainland China-listed companies, 20% reported a loss for the first time in 2024, according to a CNBC analysis of Wind Information data as of Thursday. Including companies that reported yet another year of losses, the share of companies that lost money last year rose to nearly 48%, the analysis showed.
China in March emphasized that boosting consumption is its priority for the year, after previously focusing on manufacturing. Retail sales growth have lagged behind industrial production on a year-to-date basis since the beginning of 2024, according to official data accessed via Wind Information.
Policymakers are also looking for ways to ensure “a better match between manufacturing output and what the domestic market can absorb,” Eskelund said, adding that efforts to boost consumption don’t matter much if manufacturing output grows even faster.
But when asked about policies that could address manufacturing overcapacity, he said, “We are also eagerly waiting in anticipation.”
Check out the companies making headlines before the bell: Hertz — Shares of the rental car company soared nearly 16%, extending the gains seen in the previous session. On Wednesday, the stock skyrocketed more than 56% after Bill Ackman’s Pershing Square disclosed that it had taken a sizable stake in the name. UnitedHealth — The stock plunged more than 19% after the insurer’s first-quarter results missed analysts’ estimates. UnitedHealth reported adjusted earnings of $7.20 per share on revenue of $109.58 billion, below the $7.29 in earnings per share and $111.60 billion that analysts surveyed by LSEG were looking for. The company also slashed its full-year guidance . Eli Lilly — The pharmaceutical stock surged 11% after phase-three trial results for a pill to treat weight loss and diabetes showed positive results. Taiwan Semiconductor — U.S. shares jumped more than 3% after the chipmaker’s results for the first quarter topped Wall Street’s expectations. The company also maintained its 2025 revenue forecast, noting that it has not yet seen any changes in customer behavior despite there being “uncertainties and risks from the potential impact of tariff policies.” D.R. Horton — The homebuilding stock fell more than 3% on the heels of the company posting weaker-than-expected second-quarter results. D.R. Horton earned $2.58 per share, while analysts had expected earnings of $2.63 per share, according to LSEG. Revenue of $7.73 billion also missed the consensus estimate of $8.03 billion. Alcoa — Shares dropped more than 2% after the company’s revenue of $3.37 billion for the first quarter missed expectations, with analysts calling for $3.53 billion, per LSEG. Earnings, however, came in better than expected. — CNBC’s Jesse Pound contributed reporting.
Check out the companies making headlines in midday trading: Alphabet — Shares of the megacap technology name pulled back 1.2% after a federal judge ruled that Google has illegally monopolized online advertising technology , namely the markets for publisher ad servers and ad exchanges. Hertz — The rental car company surged 50% to a 52-week high, following a 56% rally in the previous session, after Bill Ackman’s Pershing Square took a sizable stake . A regulatory filing revealed Pershing Square had built a 4.1% position as of the end of 2024. Pershing has significantly increased the position — to 19.8% — through shares and swaps, becoming Hertz’s second-largest shareholder, CNBC reported. Nvidia , Advanced Micro Devices — Shares of Nvidia dipped nearly 3% and AMD declined 1%, continuing their declines from the previous session when the chipmakers announced additional charges tied to China exports due to President Donald Trump’s tariff plans. Global Payments , Fidelity National Information Services — Global Payments announced it is acquiring Worldpay for $24.25 billion from Fidelity National Information Services and a private equity firm, and divesting its Issuer Solutions business. Shares of Global Payments fell 16%, while Fidelity National Information Services jumped 8.6%. Taiwan Semiconductor — U.S. shares jumped more than 1% after the chipmaker’s results for the first quarter topped Wall Street’s expectations. The company also maintained its 2025 revenue forecast, noting that it has not yet seen any changes in customer behavior despite there being “uncertainties and risks from the potential impact of tariff policies.” UnitedHealth — Shares of the insurer plummeted about 22% on the back of disappointing first-quarter results. UnitedHealth reported adjusted earnings of $7.20 per share on revenue of $109.58 billion, falling short of the $7.29 in earnings per share and $111.60 billion that analysts surveyed by LSEG called for. The company also slashed its full-year guidance . Eli Lilly — The pharmaceutical stock jumped 16% after Eli Lilly said its daily obesity pill showed positive results in its late-stage trials. Weight loss data, along with rates of side effects and treatment discontinuations, from the experimental pill — called orforglipron — came out in line with what some Wall Street analysts were expecting. The pill fell short of some analysts’ estimates for a key diabetes metric. Alcoa — The stock shed nearly 5% after Alcoa, one of the world’s largest aluminum producers, reported first-quarter revenue of $3.37 billion, which fell short of the forecast $3.53 billion from analysts polled by LSEG. Alcoa’s earnings came out better than expected. D.R. Horton — The homebuilding stock gained 3% despite posting weaker-than-expected second-quarter results. D.R. Horton reported earnings of $2.58 per share, while analysts had expected earnings of $2.63 per share, according to LSEG. The company’s revenue of $7.73 billion came out below the consensus $8.03 billion estimate. — CNBC’s Sean Conlon and Yun Li contributed reporting.